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Recent intriguing evidence suggests that metabolites of amyloid precursor protein (APP),
mutated in familial forms of Alzheimer’s disease (AD), play critical roles in developmental
and postnatal neurogenesis. Of note is soluble APPα (sAPPα) that regulates neural progen-
itor cell proliferation. The APP family encompasses a group of ubiquitously expressed and
evolutionarily conserved, type I transmembrane glycoproteins, whose functions have yet
to be fully elucidated. APP can undergo proteolytic cleavage by mutually exclusive path-
ways. The subtle structural differences between metabolites generated in the different
pathways, as well as their equilibrium, may be crucial for neuronal function. The implica-
tions of this new body of evidence are signiﬁcant. Miscleavage of APPwould readily impact
developmental and postnatal neurogenesis, which might contribute to cognitive deﬁcits
characterizing Alzheimer’s disease. This review will discuss the implications of the role of
the APP family in neurogenesis for neuronal development, cognitive function, and brain
disorders that compromise learning and memory, such as AD.
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INTRODUCTION
The adult mammalian brain contains pools of neural stem cells
(NSC) in two discrete regions: the subventricular zone (SVZ; Lois
Abbreviations: Aβ, beta amyloid; AD, Alzheimer’s disease; ADAM, a disintegrin
andmetalloproteinase; AICD, amyloid precursor protein intracellular domain; APP,
amyloid precursor protein; APP-BP1, APP binding protein 1; APP-CTFs, amyloid
precursor protein carboxyl-terminal fragments;APLP1, amyloid precursor-like pro-
teins 1; APLP2, amyloid precursor-like proteins 2; BACE1, β-site APP cleaving
enzyme 1; BACE2, β-site APP cleaving enzyme 2; BMP4, bone morphogenetic pro-
tein 4; BrdU, 5′-Bromo-2′-deoxyuridine; C31, caspase-cleaved APP-CTF 31 amino
acid peptide; ChIP, chromatin immunoprecipitation; CNTF, ciliary neurotrophic
factor; CuBD, copper binding domain; DAB1, disabled-1; DAPI, 4′,6-diamidino-2-
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region; RIP, regulated intra-membrane proteolysis; RMS, rostral migratory stream;
RT-PCR, real time polymerase chain reaction; sAPPα, soluble amyloid precursor
protein alpha; SGL, subgranular layer of the dentate gyrus; SHH, sonic hedgehog;
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(sex determining region Y)-box 2; STAT3, signal transducer and activator of tran-
scription; SVZ, subventricular zone; TACE, tumor necrosis factor alpha converting
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1; TGFα, transforming growth factor α; TK, thymidine kinase; TSH, thyrotropin;
VAChT, vesicular acetylcholine transporter; VGluT, vesicular glutamate transporter;
ZnBD, zinc binding domain.
and Alvarez-Buylla, 1994; Doetsch et al., 1999), lining the lateral
ventricle and the subgranular layer (SGL) of the dentate gyrus
(DG) in the hippocampal formation (Cameron et al., 1993; Kuhn
et al., 1996; Kempermann et al., 1997a). There is evidence to sug-
gest that neurogenesis takes place in the human brain as well
(Eriksson et al., 1998). In the SVZ, newly generated neural prog-
enitor cells (NPC) migrate in chains toward the olfactory bulb
(Lois and Alvarez-Buylla, 1994; Lois et al., 1996) where they are
thought to replace most of the inner granule layer and 50% of the
superﬁcial zone (Imayoshi et al., 2008). In the DG, NPC from the
SGL migrate only a short distance to the inner one-third of the
granule layer where they functionally incorporate and show char-
acteristic electrophysiological properties (van Praag et al., 2002;
Zhao et al., 2006; for review seeMing and Song, 2011). The neuro-
genic niche is thought to be a tightly regulated environment where
a combination of factors allows for the constant self-renewal and
proliferation of NSC throughout the lifespan of an organism as
displayed by the inability of SVZ NSC to proliferate and form
neurons when injected into non-neurogenic regions (Gage, 2000;
Lim et al., 2000). Individualized cross talk of the NSC and the
neurogenic niche permits cell differentiation, migration, and ulti-
mately incorporation into existing functional circuits (Reviewed
in Ihrie and Alvarez-Buylla, 2011; Ming and Song, 2011).
The functional role of neurogenesis in the adult hippocampus
has yet to be fully elucidated. Because NPC incorporate into the
DG of the hippocampus and the olfactory bulb, regions associ-
ated with different types of learning and memory, much of the
focus of the biological function of neurogenesis has been on a
potential role in these processes. The initial evidence for neuro-
genic involvement in memory formation came from the seasonal
changes in songbird neurogenesis. It was shown that the newly
born cells responded to songs and that neurogenic increases could
be correlated with seasonal and hormonal changes associated with
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song learning (Nottebohm, 2004). Studies in mammals using
different strains of mice (Kempermann et al., 1997a), environ-
mental enrichment (Kempermann et al., 1997b) and running (van
Praag et al., 1999) have each shown a correlation between increases
in neurogenesis and enhanced performance on a spatial memory
task. Conversely, experiments using different aged rats (Bizon and
Gallagher, 2003), stress paradigms (Lemaire et al., 2000), irradi-
ation (Madsen et al., 2003; Raber et al., 2004; Rola et al., 2004),
and the DNA methylating agent methylazoxy-methanol acetate
(MAM; Shors et al., 2001; Shors et al., 2002) have each shown
correlations between a decrease in neurogenesis and impairment
on hippocampal-dependent memory tasks though studies have
provided conﬂicting results as to which memory paradigms are
affected. Genetic manipulations have provided further evidence
for the role of neurogenic processes in memory formation. Dele-
tion of either neurotrophin 3 (NT-3; Shimazu et al., 2006) or
methyl-CpG binding protein 1 (MBD1), a methylated DNA bind-
ingprotein (Zhao et al., 2003),produced adecrease inneurogenesis
as well as an impairment on the Morris water-maze task. A study
using both irradiation and glial ﬁbrillary acidic protein (GFAP)-
thymidine kinase (TK) transgenic mice that express a herpes
virus TK in progenitor cells allowing for ablation of these cells
through ganciclovir administration showed that spatial memory
was retained while contextual fear conditioning was impaired.
Long-termpotentiation in theDGwas also impaired in bothmod-
els of neurogenic ablation (Saxe et al., 2006). Also of note, another
study showed the preferential recruitment of new neurons into
spatial memory networks following water-maze learning using the
expression of c-fos, an immediate early gene, to examine neuronal
excitation (Kee et al., 2007). Furthermore, an inducible deletion of
TLX from the adult mouse brain drastically reduced neurogenesis
and impaired spatial learning (Zhang et al., 2008). In that regard,
ablation of hippocampal neurogenesis by inducible Bax expres-
sion in NPC results in deﬁcits in Novelty detection, contextual
fear conditioning, place learning, and spatial navigation (Dupret
et al., 2008). Emerging evidence also suggests that neurogenesis is
crucial to pattern separation in the DG, a set of processes in which
converts similar experiences into discrete events (Clelland et al.,
2009; Sahay et al., 2011).
In the SVZ-olfactory bulb system, the functional signiﬁcance
of neurogenesis has proven more difﬁcult to elucidate. Though
NPC from the SVZ replace nearly all of the inner granule layer
and 50% of the superﬁcial zone (Imayoshi et al., 2008), abla-
tion of neural cell adhesion molecule (NCAM) in mice does not
impair olfactory discrimination learning, and impaired migra-
tion through the (RMS) due to a knock-out of Bax does not
impair olfactory discrimination or memory (Schellinck et al.,
2004; Kim et al., 2007). However, in another study of the NCAM-
null model, it was shown that alterations in NPC migration led
to a 40% reduction in inner granule interneurons and ﬁne olfac-
tory discrimination deﬁcits but normal olfactory threshold and
memory (Gheusi et al., 2000). More recent evidence has emerged
that newly generated neurons are vital to paternal and mater-
nal behaviors intimately associated with olfactory cues (Mak and
Weiss, 2010; Sakamoto et al., 2011). Short-term olfactory mem-
ory improvement associated with olfactory enrichment depends
on newborn neurons (Rochefort et al., 2002). In support of that,
ablation of new neurons in the olfactory bulb by AraC treatment
results in reduced short-term olfactory memory, but did not affect
spontaneous odor discrimination and long-term odor-associative
memory tasks (Breton-Provencher et al., 2009). In contrast, dele-
tion of new neurons in the olfactory bulb of adult mice by focal
irradiation impaired long-term rather than short-term olfactory
memory (Lazarini et al., 2009). Using a combination of behavioral
training and pharmacological treatment for the manipulation of
neurogenesis in the SVZ, Sultan et al. (2010) show that newborn
neurons participate in the neural representation of the learned
odor, which is used on recall of the task. Moreover, learning selects
new neurons to survive in an odor-speciﬁc area of the olfactory
bulb. These selected neurons are required for long-term olfaction
memory but not for task acquisition (Sultan et al., 2010).
In addition, another study suggests that a more complex olfac-
tory associated tasks such as olfactory perceptual learning seem
to require ongoing neurogenesis (Moreno et al., 2009), suggest-
ing that newly formed cells may be specially adapted to handle
ﬁne or complex olfactory function. It was recently suggested
that conﬂicting results concerning the functional signiﬁcance of
adult neurogenesis in olfaction may stem from differences in
the behavioral paradigms used in these studies. Speciﬁcally, this
study suggests that the use of an operant component, in which a
reward is associatedwith olfactory task, reinforces an active behav-
ior. This behavior represents more faithfully long-term olfaction
memory that is neurogenesis-dependent (Mandairon et al., 2011).
Regardless, the difﬁculty in obtaining consistent results concern-
ing the function of new neurons in olfaction memory and in
hippocampus-dependent memory, may underlie, at least in part,
controversial data described below, concerning the functional sig-
niﬁcance of speciﬁc metabolites in neurogenesis, and in learning
and memory.
Complementary information concerning the functional sig-
niﬁcance of neurogenesis may be obtained from learning and
memory disorders, such as Alzheimer’s disease (AD). AD is a pro-
gressive neurodegenerative disease characterized by progressive
loss of memory, impaired learning, and cognitive deterioration.
Individuals affected with the disease experience loss of olfaction-
dependent and hippocampal-dependent function. Intriguingly,
increasing evidence suggests that in mouse models of familial
Alzheimer’s disease (FAD), neurogenesis is impaired early in life,
preceding hallmarks of the disease, such as amyloid deposition, tau
hyperphosphorylation, and cognitive impairments (Li et al., 2008;
Rodriguez et al., 2008; Demars et al., 2010b; Gang et al., 2011; for
review see Lazarov andMarr, 2010). Nevertheless, the mechanism
underlying impaired neurogenesis in AD is not fully elucidated.
Familial, rare forms of the disease (FAD) are caused by mutations
in amyloidprecursor protein (APP),presenilin-1,and2 (PS1,2; For
review see Selkoe, 2001). Interestingly, it becomes clear that both
APP and PS1, the catalytic core of one of the enzymes that cleaves
APP, play a role in regulation of neurogenesis during development
and postnatally. This review will discuss emerging information of
the role of the APP family members in neurogenesis.
THE APP FAMILY
The APP family is a group of ubiquitously expressed and evolu-
tionarily conserved, type I transmembrane glycoproteins, whose
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functions have yet to be fully elucidated (Figure 1). In mammals,
this gene family includes APP, amyloid precursor-like proteins 1 &
2 (APLP1 & 2).Apl-1 andAppl are the worm and the ﬂy homolog,
respectively. The APLP’s show strong sequence homology to APP,
particularly in the C-terminal domain (Wasco et al., 1992, 1993).
APP undergoes extensive proteolysis by at least three enzymatic
activities termed α-, β-, γ-secretase, leading to the production of
a number of intra- and extracellular metabolites. Of note, APP
processing resembles Notch receptor processing (Figure 2), for
review see Hartmann et al. (2001). In the non-amyloidogenic
pathway,APP is cleaved byα-secretase, followedby regulated intra-
membrane proteolysis (RIP) by the aspartyl protease γ-secretase.
Several enzymes have been shown to have α-secretase activity
including members of the “a disintegrin and metalloproteinase”
(ADAM) family, ADAM9, ADAM10 (Lammich et al., 1999), and
ADAM17 (Buxbaum et al., 1998; Asai et al., 2003; Postina et al.,
2004) and β-site APP cleaving enzyme 2 (BACE2; Yan et al., 2001).
This cleavage event releases sAPPα to the extracellular space and
leaves amembrane-tetheredAPPC-terminal fragment (APP-CTF;
Figure 2; Sisodia et al., 1990). Recent studies suggest thatADAM10
is the major α-secretase of the brain both in development and in
the adult (Jorissen et al., 2010). Subsequent RIP by γ secretase
releases the APP intracellular domain (AICD) that can translo-
cate to the nucleus and a P3 peptide (Haass and Selkoe, 1993; Yu
et al., 2000; Kimberly et al., 2001; Francis et al., 2002). PS are the
catalytic core of the aspartyl protease γ-secretase complex (Wolfe
et al., 1999; Yamasaki et al., 2006). In the amyloidogenic cleavage
pathway, APP is ﬁrst cleaved by β-secretase to produce sAPPβ and
a βAPP-CTF. This cleavage event is mediated by β-site APP cleav-
ing enzyme 1 (BACE1;Vassar et al., 1999). Subsequent cleavage by
γ-secretase yields AICD as well as the amyloid β (Aβ) peptide that
aggregates to form the plaques that are one of the pathophysiolog-
ical hallmarks of AD (Reviewed in Selkoe, 2001). The abundance
of metabolites confers great complexity to the function of APP but
makes the interpretation of studies on APP transgenic and knock-
out mice a challenging task. Here we will attempt to dissociate
the functions of each of the metabolites as they relate to neuro-
genesis and try to understand the function of each individually to
understand how cleavage patterns may contribute to overall APP
function.
APP METABOLITES AND NEUROGENESIS
sAPPα: REGULATION OF NEURAL PROGENITOR CELL PROLIFERATION,
SURVIVAL, AND MIGRATION
Theﬁrst studies to drawa correlationbetweenAPPandneurogenic
processes showed that embryonic expression of APP peaked dur-
ing the height of neuronal differentiation and neurite outgrowth
(Hung et al., 1992; Salbaum and Ruddle, 1994). Evidence soon
emerged that the cleavage of Notch 1, an integral protein involved
in the maintenance of NSC pools by enhancing symmetric divi-
sion (Alexson et al., 2006), and APP undergo strikingly similar
proteolytic cleavage patterns by α- and γ-secretase (Figure 2; De
Strooper et al., 1999; Lavoie and Selkoe, 2003; van Tetering et al.,
2009).
Undernon-pathological circumstances, thenon-amyloidogenic
cleavage pathway of APP dominates through cleavage by α-
secretase and release of the soluble APPα (sAPPα) metabolite.
sAPPα from the predominantly neuronalAPP695 isoform contains
a series of domains that include a growth factor domain (D1), a
copper binding domain (D2), an acidic region (D3), and a car-
bohydrate domain (D6; Storey and Cappai, 1999; Reinhard et al.,
2005). Importantly, this isoform does not contain either the KPI
FIGURE 1 | APP structure. APP contains many functional domains as
illustrated. The three most abundant isoforms of APP are APP770, APP751, and
the predominantly neuronal APP695. From the N-terminal region these
domains include a heparin binding and growth factor like domain
(HBD1/GFLD), a copper binding domain (CuBD), zinc binding domain (ZnBD),
an acidic region (DE), Kunitz-type protease inhibitor domain (KPI; not present
in APP695), a second heparin binding domain (HBD2), random coiled region
(RC), and the amyloid beta domain (Aβ). The inset displays the human amyloid
beta sequence in red along with the sites of APP cleavage by α-, β-, and
γ-secretase.
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FIGURE 2 | APP processing: similarities to Notch processing. Both APP
and Notch receptor may undergo proteolytic cleavage by α-secretase. In
the case of APP, this cleavage prevents the formation of beta-amyloid (Aβ)
peptides, and induces the release of the p3 fragment and the retention of
a membrane-tethered fragment [carboxyl-terminal fragments of APP
(APP-CTFs)], that is a substrate of γ-secretase cleavage, yielding APP
intracellular domain (AICD) fragments. In the alternative, amyloidogenic
pathway, APP is cleaved by β-secretase prior to γ-secretase. In the case of
the Notch receptor, the holoprotein is cleaved in the trans Golgi network
by a furin-like protease activity in the juxtamembrane extracellular domain,
giving rise to two fragments (120 and 180 kDa) that remain associated as a
heterodimer. It is thought that Notch reaches the cell membrane in this
assembly, where it can undergo activation by ligand binding, following
which it gets cleaved by α-secretase to yield the “Notch extracellular
truncated” derivative (NEXT). Similarly to the APP-CTFs, only this
truncated derivative is then cleaved by γ-secretase. Similarly to NICD,
AICD fragments are thought to translocate to the nucleus and activate
gene transcription.
domain (D4) or the OX-2 domain (D5; Figure 1; Sandbrink et al.,
1996). A crystal structure of sAPP suggests that the growth factor
like domain is similar to cysteine-rich growth factors (Rossjohn
et al., 1999). In light of the appearance of a growth factor like
domain, it is not surprising that addition of sAPPα stimulates the
proliferation of a number of different cell types. However, the cel-
lular role of sAPPα seems to be broader than that (Table 1). Speciﬁ-
cally, sAPPα stimulates theproliferationof ﬁbroblasts (Saitoh et al.,
1989), thyroid epithelial cells (Pietrzik et al., 1998), epidermal basal
cells (Hoffmann et al., 2000), embryonic stem cells (Ohsawa et al.,
1999), and carcinoma cells (Ko et al., 2004). Takayama et al. (2009)
suggest that sAPP promotes androgen-dependent proliferation of
prostate cancer cells and tumor growth, however, it is yet to be
determined whether this effect is solely due to sAPP. Caille et al
(2004) showed that rapidly proliferating, EGF-responsive type-C
cells of the adult SVZ had saturable binding sites for sAPPα and
infusion of sAPPα into the lateral ventricles of adult mice was
sufﬁcient to increase NPC numbers (Caille et al., 2004). Recent
evidence suggests that inhibiting α-secretase activity reduces NPC
proliferation in vitro, and that proliferation can be rescued by the
addition of recombinant sAPPα into the medium (Demars et al.,
2011). In support of that, a recent study suggests that both sAPPα
and sAPPβ increase the proliferation of NPC derived from the
SGL and the SVZ of adult rats in vitro, and enhances their glial
fate (GFAP immunoreactivity; Baratchi et al., 2011). It is yet to
be determined if the observed enhanced GFAP immunoreactiv-
ity is due to lack of differentiation or due to more differentiation
into astrocytes. In addition, the studies by Demars et al. suggest
that sAPPα is not only a potent proliferation factor for adult NPC
but for mesenchymal and human placental stem cells as well and
that this signaling may be accomplished through the mitogen-
activated protein (MAP)-kinase pathway, a pathway integral to
Frontiers in Neuroscience | Neurogenesis June 2012 | Volume 6 | Article 81 | 4
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NPC proliferation (Li et al., 2001; Jin et al., 2005; Sung et al.,
2007; Demars et al., 2011). The observation that sAPPα regulates
the proliferation of non-NSC may suggest a potential explanation
for the ubiquitous expression of APP and ADAMs. Furthermore,
studies on a mouse model exhibiting a knockout of the sortilin
related receptor with type-a repeats (SORLA), a sorting recep-
tor that inhibits the processing of APP to form both sAPP and Aβ,
showed both increasedAPPmetabolites as well as enhanced prolif-
eration of NPC and neurogenesis in adult mice (Rohe et al., 2008).
Interestingly, following cerebral stroke, an increase in ADAM17
proteolytic activity andAPP expression leads to increased prolifer-
ation in the SVZ (Katakowski et al., 2007). It is yet to be determined
whether the sAPP effect on proliferation of NPC and other cell
types is a result of an effect on cell survival or proliferation per se.
Survival of NPC is an integral, often rate limiting step, in
the functional incorporation of newly generated neurons. It is
estimated that under normal conditions in the DG only approxi-
mately 50% of newly generated neuroblasts survive (Cameron and
McKay, 2001). Many neurodegenerative conditions including AD
(Verret et al., 2007; for reviewLazarov andMarr,2010),Parkinson’s
disease (Hoglinger et al., 2004), and Huntington’s disease (Phillips
et al., 2005; Lazic et al., 2006) present with detriments in neuroge-
nesis that may be, at least in part, attributable to alterations in the
niche microenvironment. Several studies suggest that sAPPα has
a neuroprotective function in association with Aβ toxicity in neu-
rons (Goodman and Mattson, 1994), following traumatic brain
injury (Thornton et al., 2006) and excitotoxic infarcts (Masliah
et al., 1997). Recent evidence suggests that sAPP may promote
cell survival through the disruption of APP dimerization (Gralle
et al., 2009). sAPPα also shows a cytoprotective role in human ker-
atinocytes cultured in the absence of fetal calf serum and bovine
pituitary extract (Wehner et al., 2004).Alteration in the subcellular
localization of APPL in a null-mutant of yata induces progressive
eye vacuolization, brain volume reduction, and lifespan short-
ening (Sone et al., 2009) suggesting that survival of neurons is
impaired. While the direct function of sAPP with relation to sur-
vival of newly generated neurons has not been fully determined,
it is interesting to speculate that sAPP could regulate the physi-
ological survival of NPC and newly generated neurons as well as
the survival of NPC under pathological conditions such as those
present in neurodegenerative disease.
As the developmental expression of APP corresponds to the
timing of neuronal differentiation, it was postulated that APP or
APP metabolites might play a role in the neuronal differentia-
tion of NPC. However, transgenic expression of human wild-type
APP in the hippocampus of mice disrupted the neuronal differ-
entiation associated with environmental enrichment (Naumann
et al., 2010). Nevertheless, the overexpression of hAPP is under the
neuronal-speciﬁc PDGF-β promoter, and it is not clear whether
it is expressed in NPCs as well. Treatment of human NPC with
APP also caused a shift toward glial differentiation suggested to
be driven by an induction in Notch 1 signaling (Sugaya, 2008;
Kwak et al., 2011). In adult bone marrow adult progenitor cells
and human embryonic stem cells, sAPPα induced neuronal phe-
notype in (Chen et al., 2006; Freude et al., 2011). Taken together
these results highlight the importance of APP metabolites in cell
lineage commitment, and the importance of a direct investigation
of the role of speciﬁc APP metabolites in the proliferation and
differentiation of NPC. It remains a likely possibility that APP
metabolites affect the fate of NPCdifferentially. A special attention
should be paid to the neurogenic microenvironment from which
these cells are derived, and the proper tools must be implemented
in order to resolve these outstanding questions.
Another key factor in the functional integration of newly gen-
erated neurons into the proper functional circuits is the migration
of neuroblasts, often over long distances in the case of the adult
SVZ. Little is known about the effect of sAPP on the migration
of neuroblasts, however, administration of nanomolar concen-
trations of sAPP to epithelial cells, thyrocytes, and keratinocytes
in vitro caused a marked increase in not only the proliferation of
the cells but also their migration (for review see Schmitz et al.,
2002). Thus, sAPP might be a part of a long list of motogens,
growth factors (such as EGF), regulating both cell proliferation
and migration. In keratinocytes it was shown that this mitogenic
property was conferred through a chemo-attraction similar to,
but distinct from, EGF (Kirfel et al., 2002). Thus an upregula-
tion of sAPP as seen following stroke could suggest its utility as a
chemoattractant guiding NPC to the site of injury in an attempt at
recovery. During development, an shRNA mediated knockdown
of endogenous APP leads to an increase in NPC that remain in
the intermediate zone. Conversely, overexpression of APP in the
developing brain leads to migration of progenitors past the corti-
cal plate boundary (Young-Pearse et al., 2007). Further analysis
revealed that the C-terminus of APP may interact transiently
with the N-terminus of disrupted in schizophrenia 1 (DISC1)
altering the subcellular localization of DISC1. Both DISC1 and
disabled-1 (Dab1) seem to operate downstream of APP to impact
migration (Young-Pearse et al., 2007, 2010). These results suggest
that a proper balance of APP expression is necessary for cortical
migration during development.
In order to fullymature and functionally incorporate into exist-
ing neural networks, a developing neuron must sprout neurites,
form dendritic spines and develop synapses. In rat neocortical
explant cultures, treatment with sAPP-induced neurite outgrowth
which could be blocked by the addition of 22C11 antibodies
that recognize the N-terminal domain of APP (Ohsawa et al.,
1997). Qiu et al. (1995) showed that APP transfected CHO cells
co-cultured with rat primary hippocampal neurons caused an
increase in neurite elongation. However, sAPP in the conditioned
media was unable to replicate this effect and peptides blocking
sAPP failed to disrupt what is an apparent cell surface function
of full length APP (Qiu et al., 1995). It was shown that in vitro
depolarization of immature neurons derived from either embry-
onic striatal NPC or early postnatal SVZ NPC, stimulated neurite
outgrowth. Inhibition of sAPP secretion through a blockade of
α-secretase activity or inactivation of sAPP by antibody adminis-
tration could abolish depolarization-induced neurite outgrowth.
Further, administration of recombinant sAPPα alone was sufﬁ-
cient to promote neurite outgrowth in these cells through stimu-
lation of the MAP-kinase pathway (Gakhar-Koppole et al., 2008).
A 17-mer peptide mimicking the trophic domain of sAPP signif-
icantly enhanced synaptic density and memory retention when
injected into rat brains (Roch et al., 1994). Another study utilizing
a moderately overexpressing ADAM10 mouse model showed an
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increase in cortical synaptogenesis of cholinergic, glutamatergic,
and GABAergic synapses at both 8 and 18months of age. In order
to rule out other ADAM10 substrates, the authors infused sAPPα
into non-transgenic mice for 1week and showed similar results
suggesting that sAPPαmediates synaptogenesis of these neuronal
populations (Bell et al., 2008).
AICD: A NEGATIVE REGULATOR OF NEUROGENESIS
The AICD is formed following cleavage of APP by either α- or
β-secretase and subsequent RIP through the activity of the γ-
secretase complex (Haass and Selkoe, 1993; Kimberly et al., 2001).
It has been shown to contain a YENPTY domain that is a bind-
ing site for phosphotyrosine binding domain-containing adapter
proteins (Kavanaugh and Williams, 1994). The AICD itself can
also undergo modiﬁcation through phosphorylation events that
may underlie docking of some of its many adapter proteins (Tarr
et al., 2002). TheAICD has been shown to form a transcriptionally
active complex with Fe65 and Tip60, a histone acetyltransferase,
that translocates to the nucleus and regulates transcription of a
number of genes (Cao and Sudhof, 2001; Gao and Pimplikar,
2001; Muller et al., 2008). Much interest has evolved in the rela-
tionship between AICD and neurogenesis due to the ﬁnding that
the cleavage pattern, formation of an ICD, and its translocation
to the nucleus mimic the integral neurogenesis protein Notch 1
(Figure 2, for review Ebinu and Yankner, 2002).
Conversely to sAPPα function, AICD has been shown to be a
negative regulator of proliferation in NPC. First, evidence suggests
that AICD negatively regulates the transcription of the epider-
mal growth factor receptor (EGFR), a receptor that drives NPC
proliferation (Zhang et al., 2007b; Ayuso-Sacido et al., 2010).
Ma et al. showed that the glycophosphatidylinositol (GPI)-linked
recognition protein, TAG1, extracellularly interacts with APP to
increase AICD release. Using a TAG1 null mousemodel with aber-
rantly high proliferation of embryonic NPC, they showed that
either administration of recombinant TAG1 or transfection with
AICD59 in vitro could ameliorate enhanced neurogenesis. How-
ever, transfection of AICD with a mutated Fe65 binding site had
no effect (Ma et al., 2008). This suggests that AICD is a negative
regulator of NPC proliferation and that the binding to Fe65 is
necessary for its action. Additionally, in APPKO mice expressing
AICD there is a reduction in proliferation and survival of NPC
in the adult DG, but no change in their differentiation. Notably,
this deﬁcit in neurogenesis is Aβ-independent, and is suggested to
be due, at least in part, to neuroinﬂammation in light of the fact
that ibuprofen or naproxen treatment could reverse these alter-
ations (Ghosal et al., 2010). In trisomic NPC, enhanced AICD
binding to the sonic hedgehog (shh) receptor, patched1 (ptch1),
promoter was sufﬁcient to decrease proliferation. Shh binding to
ptch1 results in the suppression of second receptor smoothened
(Smo) and repressed signaling (Goodrich et al., 1999; Taipale et al.,
2002; Trazzi et al., 2010). Interestingly, in post-mitotic neurons it
has been suggested that the interaction of the intracellular domain
of APP with APP binding protein 1 (APP-BP1) results in re-entry
to the cell cycle and ultimately apoptosis (Chen et al., 2003).
The targeted cell death of newly formed neurons, as in embry-
onic development, may be an important factor underlying func-
tional adult neurogenesis. Indeed, the evidence that only 50% of
newly generated neurons in the adult hippocampus survive sug-
gests that targeted cell death is a physiological property and some
speculate the tight regulation may be important to normal func-
tion. The induction of apoptosis seems to be a common theme in
studies of AICD function. Unlike sAPP, which serves a cytoprotec-
tive role, the AICD has been shown to induce neuronal apoptosis.
The ﬁrst evidence for this came from APP overexpression stud-
ies in post-mitotic neurons in vitro. The overexpression of APP
was shown to be sufﬁcient to cause apoptosis in these neurons
(Yoshikawa et al., 1992). Further, studies on embryonic carcinoma
P19 cells overexpressing AICD display neuron speciﬁc apopto-
sis upon differentiation as shown by TUNEL+Tuj-1+ positive
cells. This group suggests that gene changes associated with AICD
translocation are responsible for the apoptotic events (Nakayama
et al., 2008; Ohkawara et al., 2011). Indeed, research from other
groups has shown that AICD interaction with Tip60 in H4 cells
derived from human neuroglioma cells (Kinoshita et al., 2002) or
p53 in either H4 neuroglioma or SH-SY5Y neuroblastoma cell line
(Ozaki et al., 2006) can mediate AICD driven apoptotic events.
Alternatively, the APP-CTF can be cleaved by caspases to form
a 31 amino acid peptide (C31) that signals apoptotic cell death
through initiator caspases 8 and 9 in rat neuroblastoma cell line
(Bertrand et al., 2001; Lu et al., 2003) and in embryonic mouse
cortical cultures (Bertrand et al., 2001). This cleavage appears to
be regulated by Aβ and C31 was shown to be upregulated in the
brains of AD patients (Bertrand et al., 2001; Lu et al., 2003). Cur-
rently, it is not known whether AICD or C31 induced apoptosis
occurs under physiological conditions and thus may represent a
purely pathological phenomenon in AD brains.
Cytoskeletal dynamics are an important function in the mat-
uration of neurons, including growth cone elongation (Geraldo
and Gordon-Weeks, 2009) and dendritic spine formation (Hotu-
lainen and Hoogenraad, 2010). Sabo et al. (2001, 2003) showed
that APP and Fe65 binding in dynamic adhesion actin-rich sites
could induce enhanced migration inMDCKwound healing assay.
Further, they show the localization of APP/Fe65 complexes in
synapses and growth cones. More recently, utilizing an inducible
expression system for either AICD, Fe65 or AICD, and Fe65
in a human neuroblastoma cell line, Tet21, it was shown that
AICD expression activated genes associated with actin remodel-
ing including transgelin and tropomyosin 1 and co-expression of
AICD and Fe65 induced enhanced cytoskeletal dynamics (Muller
et al., 2007).
Aβ: A PUZZLING METABOLITE
The Aβ peptide is produced from the sequential cleavage of APP
by β- and γ-secretase and is most well known for its aggregation
to form amyloid plaques in AD. Studies on the effect of Aβ with
respect to NPC proliferation have generally met with conﬂicting
results. Haughey et al. (2002a) showed that treatment with Aβ
in human cortical NPC culture in vitro and following intraven-
tricular infusion of Aβ in vivo, NPC proliferation was drastically
reduced (Haughey et al., 2002a; He and Shen, 2009). He and Shen
(2009) observed that Aβ could reduce β-catenin signaling and
propose this as a mechanism for Aβ action. These ﬁndings were
in agreement with the observation that Aβ restricted the forma-
tion of colonies from human NPC (Mazur-Kolecka et al., 2006).
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However, other studies have shown that Aβ could stimulate the
proliferation of adult murine SVZ derived NPC (Lopez-Toledano
and Shelanski, 2004) and that this action may be through the
p75 neurotrophin receptor (Sotthibundhu et al., 2009). This con-
tradiction may be due to the use of different isoforms of Aβ
or the use of NPC of different species or culture system, and
potentially different aggregation states of Aβ. Thus the physio-
logical role of Aβ with respect to proliferation of NPC remains
unclear.
Studies have also shown that Aβ may play a role in the fate
determination of NPC. One such study determined that treat-
ment of SVZ derived NPC with oligomeric Aβ42 induced both
proliferation and pushed differentiation toward a neuronal fate
in vitro, as determined by both Western blotting for NCAM and
immunohistological analyses. In addition, the authors showed
that oligomeric Aβ42 enhanced the migration of immature neu-
rons, in vitro. Increasing concentrations, however, proved to be
neurotoxic (Heo et al., 2007). Chen and Dong (2009) showed
that Aβ40 was sufﬁcient to promote neuronal differentiation in
embryonic cortical NPC culture, while Aβ42 induced astrocytic
differentiation.
While studies that attempt to uncover the physiological sig-
niﬁcance of the p3 peptide derived from γ-secretase cleavage in
the non-amyloidogenic pathway are virtually non-existent, the
above discussion of the effects of APP metabolites in relation
to neurogenesis suggest great complexity in potential signaling.
The complexity of cleavage and the number of metabolites pro-
duced confer great convolution in the study of APP function.
By attempting to understand the physiological role of each indi-
vidual metabolite, we are able to better understand the signal-
ing pathways associated. However, most of these studies have
been done in vitro and in many cases do not represent the
interplay of cleavage events that potentially takes place in vivo.
While it is advisable to understand the role of each metabo-
lite individually, understanding the interplay of these metabolites
may be the key to understanding the true role of APP in neu-
rogenic processes (Figure 3). Parsing out the individual roles
of APP metabolites with respect to neurogenesis in transgenic
models has proven complex as well. Not only is the metabo-
lism of APP intricate but the potential functional redundancy
of APP homologs APLP1 & 2 has only enhanced the complex-
ity of understanding APP function. To attempt to understand how
we may approach new models for the study of APP metabolites
and APP in neurogenesis we will review the models currently
available for this purpose and highlight the deﬁciencies of each
(Table 2).
ALZHEIMER’S DISEASE ANIMAL MODELS: ADEQUATE FOR THE
EXAMINATION OF NEUROGENESIS?
The ﬁrst transgenic models to delve into the question of APP
function in neurogenesis were FAD mutants that possess either
mutations in APP or PS1, most times causing a shift in cleav-
age patterns toward the amyloidogenic pathway, up-regulating β-
or γ-secretase cleavage and producing higher levels of Aβ (for
review Selkoe, 2001). The effect of these mutations on neurogenic
processes has been reviewed extensively (Lazarov andMarr, 2010).
Brieﬂy, APP mutants have been shown to have both decreased
(Haughey et al., 2002a,b; Donovan et al., 2006) and increased
(Lopez-Toledano and Shelanski, 2007; Kolecki et al., 2008) pro-
liferation of NPC derived from the SGL or the SVZ of adult
transgenic mice. In mice exhibiting mutations in both APP and
PS1, studies have for the most part shown impaired proliferation
(Taniuchi et al., 2007; Zhang et al., 2007a; Ermini et al., 2008).
These studies have all shown impairments in mice after amy-
loid deposition and plaque formation. As we ﬁrst described in the
APPSwe/PS1ΔE9 mouse, impairments in proliferation, and neu-
rogenesis occur before memory impairment or pathological alter-
ations in these mice (Demars et al., 2010a). Furthermore, when
NPC are cultured from the SVZ of 2-month-old APPSwe/PS1ΔE9
mice, they show impairments in proliferation in vitro suggesting
that mutations may cause intrinsic impairments in NPC prolifer-
ation irrespective of environmental or niche cues (Demars et al.,
2010a).
In order to determine a physiological role for APP, the ﬁrst
logical step was to create an APP-null mouse model and to infer
from any impairment what the function of APP may be. Surpris-
ingly, the APP knockout mouse was viable and fertile, giving the
ﬁrst clue that APP homologs may possess functional redundancy
with APP. The mice weighed 15–20% less than their wild-type lit-
termates and showed impaired locomotor activity and decreased
forelimb grip strength. In the CNS, the only gross alteration was
a reactive gliosis in some mice (Zheng et al., 1995, 1996). Fur-
ther investigation revealed thatAPP-null mice did exhibit reduced
brain weight, reduced size of forebrain commissures, and an
increased frequency of neuroanatomical abnormalities such as cal-
losal agenisis but these effects were mouse background speciﬁc
(Magara et al., 1999). APP-null mice also showed aging linked
impairments in dendritic length and synaptic plasticity along with
both decreased long-term potentiation and impaired GABAer-
gic post-synaptic currents. These mice also display aging linked
impairments learning andmemory (Dawson et al., 1999; Seabrook
et al., 1999). Another model of APP deﬁciency that utilizes a trun-
cated mutant lacking amino acids 20–75 and expressed at 5% of
normal levels (APPΔ/Δ) also shows abnormalities such as callosal
agenesis, reduced brain weight, and decreased locomotor activ-
ity (Muller et al., 1994; Magara et al., 1999). The APPΔ/Δ mice
also showed cognitive impairments associated with swimming
navigation during the Morris water-maze task and an apparent
decline in motivation to avoid a noxious stimuli (Muller et al.,
1994). Interestingly, mice tested at early postnatal stages (pd 3–
10) did not show impairments while major impairments only
became evident at later postnatal stages (pd 11–19) and while
reduced grip strength persisted into adulthood, deﬁcits in spa-
tial learning, contrary to phenotypic expectation, could not be
shown (Tremml et al., 1998). Further investigation revealed that
handling during these early periods resulted in rescued impair-
ment in spatial learning as tested by the Morris water-maze but
failed to rescue impaired activity in an open ﬁeld test (Tremml
et al., 2002). This result suggests that impairments caused by APP
deﬁciency do not completely disrupt plasticity or the ability of
environmental enrichment to enhance cognitive function. In fact,
studies on NPC derived from E14 APP-null mice showed aber-
rantly increased neurogenesis (Ma et al., 2008). While the direct
affect of APP disruption on neurogenesis in vivo in the adult has
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FIGURE 3 | APP metabolites in neurogenesis.The formation of new
neurons or astroglia in the adult brain is a multifaceted process including the
necessity of a niche that supports continuous proliferation of neural
progenitor cells, the determination of neural lineage, migration of immature
cells often across large distances, and the functional incorporation into
existing neural networks. Many of the metabolites of APP have been
implicated in one or more of these processes. In order to fully understand the
impact of APP metabolism on neurogenic processes, we must ﬁrst unravel
the individual functions of each of the metabolites in order to better realize
the implications of alterations in the cleavage pattern of APP.
not been reported, studies on a PDGF-APPWT mouse line overex-
pressing human APP have shown that the overexpression results
in decreased proliferation of NPC in the adult hippocampus, an
increased survival rate of these NPC and impaired maturation of
NPC to either neural or glial fate (Naumann et al., 2010). How-
ever, these animals have also been shown to display high levels
of Aβ42, synaptic dysfunction, neuronal degeneration, and alter-
ations in isoform expression patterns (Rockenstein et al., 1995;
Mucke et al., 2000; Simon et al., 2009). Deletion of APP homologs,
APLP1 and APLP2, has also been attempted. Like APP-null mice,
both APLP1 and APLP2 knockout mice are viable and fertile (von
Koch et al., 1997;Heber et al., 2000).APLP2 knockoutmice present
with normal size and weight, no gross tissue abnormalities, nor-
mal grip strength, normal posture, and no apparent cognitive
deﬁcits (von Koch et al., 1997). This is in contrast to APP-null
mice which exhibit reduced weight, forelimb grip strength, and
aging linked cognitive deﬁcits. Mice exhibiting a knockout of
APLP1 show approximately 10% reduction in body weight but
are absent of most other abnormalities associated with APP-null
mice including grip strength, locomotor activity, callosal agene-
sis, and spatial learning (Heber et al., 2000). The generation of
mouse lines designed to either ablate or overexpress APP and APP
homologs present a number of problems with respect to the study
of APP function. First, the APP family has been shown to con-
fer much of its activity through its extensive proteolytic cleavage
and release of variousmetabolites. Many of thesemetabolites have
been shown to have potential synergistic and/or antagonistic activ-
ities on a number of different cellular processes. The regulation of
APP function may not be solely driven by the expression of APP,
but through the activity of proteases and formation of metabo-
lites. Simply ablating APP or APP homologs may be valuable in
discerning the dominant pathway but does not necessarily segre-
gate between physiological signaling pathways of APPmetabolites.
Second, a number of processes have been shown to affect neu-
rogenesis including neuronal excitability, learning, inﬂammation,
physical activity, enriched environment, and stress among others
(Reviewed inMing and Song, 2005). None of the knockoutmodels
described above infer spatial or temporal speciﬁcity. As such, all
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Table 2 | APP animal models and neurogenesis.
Genetic
manipulation
Reference Genotype Phenotype Neurogenesis
Single knockout Zheng et al. (1996,
1995)
APPKO Viable and fertile; reduced brain weight; reactive
gliosis; reduced locomotor activity and forelimb grip
strength; reduced dendritic length, LTP and
GABAergic post-synaptic currents; aging linked
memory impairment.
Increased neurogenesis of NPC
derived from APPKO E14 embryos
In vitro; Increased expression of
neurogenesis-related genes.
Heber et al. (2000) APLP1KO Viable and fertile; reduced body weight. N/A
von Koch et al.
(1997)
APLP2KO Viable and fertile; no major abnormalities. N/A
Double
knockout
Heber et al. (2000) APP/APLP1KO Viable and fertile. N/A




Postnatal lethality; defects at neuromuscular and
interneuronal synapses; in vitro reduced EPSPs;
reduced keratinocyte proliferation.
N/A
Heber et al. (2000) APLP1/
APLP2KO
Postnatal lethality; no gross abnormalities. N/A
Triple knockout Herms et al. (2004) APP/APLP1/
APLP2KO
Postnatal lethality; lissencephaly; abnormal neuroblast
migration.
Normal migration, polarity, and
ability to form functional synapses





PDGF-APPWT Viable and fertile; reduced presynaptic terminals. Reduced NPC proliferation in the
SGL; Increased NPC survival;




Muller et al. (1994) APP(Δ/Δ) Viable and fertile; callosal agenesis; reduced brain
weight; reduced locomotor activity; impaired
swimming navigation; reduced motivation to avoid




Ring et al. (2007) APPΔCT15-KI Viable and fertile; rescues impairments associated
with APPKO
N/A






Li et al. (2010) APPsβ-KI Unable to rescue postnatal lethality of APP/APLP2KO;
impaired neuromuscular synapses.
N/A
Weyer et al. (2011) sAPPα-DM Rescues postnatal lethality of APP/APLP2KO;
impaired neuromuscular synapses; hippocampal
dysfunction; impaired LTP; spatial learning deﬁcits.
N/A
APPKO/AICD Ghosal et al. (2010) FeCυ25;
APP−/−






Mallm et al. (2010) APP(Δ/−) Viable and fertile; reduced grip strength, brain, and
body weight
N/A
Mallm et al. (2010) APLP2(Δ/−) Viable and fertile N/A
A list of the currently available mouse models to study APP and APP family members. The general phenotype of each is described in brief as well as a description of
any work that has been done with respect to neurogenesis in each mouse model.
systems, cell types and regions are void of APP or APP homologs.
Lack of cell type speciﬁcity could lead to alterations in mature
neuronal or glial function that could alter neurogenic processes.
Impaired LTP (Seabrook et al., 1999), decreased locomotor activ-
ity or reactive gliosis (Zheng et al., 1995) as seen in APP-null mice
could compromise the study of neurogenesis in thesemice. Lack of
temporal regulation could also compromise the studyof APP func-
tion by allowing for compensatory alterations during development
that may mask some of the functions of the protein. Finally, func-
tional redundancy between the homologs could hinder the study
of single knockouts by masking the role of a single homolog. For
example,APP-null mice express bothAPLP1 andAPLP2 and were
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shown to be viable and fertile despite the belief that APP plays a
major role in development.
To overcome the issue of redundancy APP/APLP1 knock-
out, APP/APLP2 knockout, APLP1/APLP2 knockout, and
APP/APLP1/APLP2 triple knockout mice were generated (Heber
et al., 2000; Herms et al., 2004). APP/APLP2 and APLP1/APLP2
knockout mice proved to be postnatally lethal, while APP/APLP1
knockoutmice were viable and fertile (vonKoch et al., 1997;Heber
et al., 2000). These results further suggest a functional redun-
dancy between various APP homologs and imply that various
homologs may be involved in differential functions. At ﬁrst there
seemed to be few gross abnormalities in double knockouts, even
in mice that were postnatally lethal. However, further investiga-
tion has revealed that APP/APLP2 double knockout mice have
defects at neuromuscular synaptic junctions including increased
nerve terminal sprouting, reduced presynaptic vesicles, deﬁcits
in neurotransmitter release, and a higher incidence of synaptic
failure (Wang et al., 2005). This phenomenon was also seen in
interneuronal synapses at the submandibular ganglion (Yang et al.,
2005). In neurons derived from APP/APLP2 knockout embry-
onic stem cells, a decrease in vGLUT2 was correlated with a
reduction in ﬁeld excitatory post-synaptic potentials signaling fur-
ther impairments in neuronal function (Schrenk-Siemens et al.,
2008). Keratinocyes derived from APP/APLP2 double knockout
mice also show impaired proliferation in vivo and in vitro that
can be rescued by exogenous addition of sAPPα (Siemes et al.,
2006). APP and APLP2 have been implicated in lipoprotein and
cholesterol metabolism in the brain as well through modula-
tion of the expression of LRP1, a major lipoprotein receptor.
APP/APLP2 knockout mice show increased expression of LRP1
that is directly attributable to the lack of AICD as AICD was
shown to bind to the LRP1 promoter and repress transcription
(Liu et al., 2007). Insulin and glucose homeostasis was shown to
be impaired in APP/APLP2 double knockout even further than
that of single knockouts, which grow to hypoglycemic adults
(Needham et al., 2008). The APP/APLP1/APLP2 triple knockout
appears to have the most severe phenotype with cranial abnor-
malities and cortical dysplasia resembling type 2 lissencephaly
where neuroblasts have migrated through the basal lamina and
pial membrane (Herms et al., 2004). This phenotype would sug-
gest a critical role for the APP family in migration and adhesion.
However, embryonic stem cells derived from triple knockouts
were reported to show normal migration, polarity, and to form
functional synapses (Bergmans et al., 2010). While these models
addressed the downfall of previous models in so much as they
accounted for functional redundancy, they nonetheless failed to
address which metabolite could be ascribed to each phenotypic
change in these mice. Ring et al. (2007) addressed this question
by developing a pair of mutant mice, one a sAPPα knock-in
and the other an APP knock-in with a truncated C-terminus
lacking the YENPTY motif, to understand if sAPPα could res-
cue impairments associated with the APP-null mouse. Indeed,
bothmutants either attenuated or completely reversed phenotypic
alterations in APP-null mice including brain and body weight,
locomotor deﬁcits, grip strength impairment, exploratory behav-
ior, long-term potentiation, and spatial learning deﬁcits (Ring
et al., 2007). Studies using similar knock-in models crossed with
an APLP2 knockout mutant showed mixed results with the addi-
tion of sAPP recovering postnatal lethality in one of the models
but unable to ameliorate postnatal lethality in the other (Li et al.,
2010; Weyer et al., 2011). Both studies showed that impairments
in neuromuscular synapses persisted in sAPPα knock-in double
mutants. Further, Weyer et al. (2011) went on to show that while
sAPPα knock-in double mutants had normal CNS morphology,
they displayed hippocampal dysfunction, spatial learning deﬁcits,
and impaired long-term potentiation (Weyer et al., 2011). Analy-
sis of differential mRNA expression in the prefrontal cortex of
adult wild-type, APP-null, APLP2 knockout, and sAPPα knock-in
mice showed that APP-null and sAPPα knock-in mice had very
similar proﬁles suggesting a potentially dominant role of AICD
in transcriptional regulation (Aydin et al., 2011). Recently, the
development of APP and APLP2 conditional knockout mice has
been accomplished with the hope that they may be crossed with
viable single knockouts to allow for postnatal and adult study
of the effect of these ablations. The APP conditional knockout
mice showed similar deﬁcits in brain weight, body weight, and
grip strength to the classic APP-null mouse model (Mallm et al.,
2010).
In order to develop better mouse models designed to study the
physiological role of APP family members with respect to neu-
rogenic processes, three crucial factors must be considered. First,
it has become apparent that APP family members exhibit some
degree of functional redundancy and thus models such as the
double and triple knockouts of the APP family of proteins poten-
tially provide critical phenotypic evidence that is masked in single
knockouts. This may be essential to understanding the individual
roles of APP homologs and ultimately understanding the function
of the APP family. Simply examining the nature of knockouts of
holo-APP family members, however, does not take into account
the proteolytic processing and potential for metabolites to exert
synergistic or antagonistic roles on certain neurogenic processes.
Models such as the APP/APLP2 knockout sAPPα knock-in or the
APP-null AICD mice allow for examination of the expression of
a single metabolite and may allow for better understanding of
the role of each in neurogenic function. Further, study of NPC
derived from knockout models may allow for the exogenous addi-
tion of soluble factors or expression of metabolites such as AICD,
permitting their study in vitro. Finally, none of the APP mouse
models to date have provided for temporal and spatial regulation
of ablation or expression. Utilizing technology such as inducible
knockout systems, promoter selection for NPC speciﬁcity and
lentiviral expression for reintroduction of single APP metabolites
may provide a more precise system in which to study the direct
effect of each metabolite on neurogenic processes. As technology
develops, inducible systems will provide the greatest control over
temporal and spatial transgenic expression and have the ability to
greatly enhance our understanding of the APP family and their
metabolites.
CONCLUSION REMARKS
The increasing knowledge of the role of APPmetabolites in devel-
opmental andpostnatal neurogenesis opensupnewresearchdirec-
tions thatmay lead to greater understanding of cognitive pathways
in health and brain disorders. The APP is a family of ubiquitously
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expressed homologs, some of which exhibit functional redun-
dancy. APP yields a complex set of proteolytic metabolites.
New animal models are required in order to dissect out the
functional signiﬁcance of each APP metabolite and their role in
neurogenesis.
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